Matt Hewitt
Stock Analyst at Craig-Hallum
(3.38)
# 929
Out of 4,876 analysts
43
Total ratings
51.35%
Success rate
4.15%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $45 → $36 | $16.86 | +113.52% | 8 | Jun 13, 2025 | |
| CSBR Champions Oncology | Maintains: Buy | $8 → $12 | $7.76 | +54.64% | 4 | Mar 12, 2025 | |
| CLOV Clover Health Investments | Initiates: Buy | $6 | $2.76 | +117.39% | 1 | Dec 17, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $21.49 | +48.91% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $29.38 | +117.84% | 6 | Oct 31, 2024 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $135 → $140 | $114.15 | +22.65% | 3 | Jul 9, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $1.70 | +488.24% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $20.61 | +45.56% | 3 | May 2, 2024 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $2.20 | +218.18% | 1 | Nov 29, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $123.56 | +61.86% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.70 | +488.24% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $8.41 | +256.72% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $0.91 | +43,856.04% | 1 | Jan 4, 2022 |
Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45 → $36
Current: $16.86
Upside: +113.52%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $7.76
Upside: +54.64%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.76
Upside: +117.39%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $21.49
Upside: +48.91%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $29.38
Upside: +117.84%
Ligand Pharmaceuticals
Jul 9, 2024
Maintains: Buy
Price Target: $135 → $140
Current: $114.15
Upside: +22.65%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $1.70
Upside: +488.24%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $20.61
Upside: +45.56%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $2.20
Upside: +218.18%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $123.56
Upside: +61.86%
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.70
Upside: +488.24%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $8.41
Upside: +256.72%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $0.91
Upside: +43,856.04%